These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34375027)

  • 21. Mapping the configurational landscape and aggregation phase behavior of the tau protein fragment PHF6.
    Pretti E; Shell MS
    Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2309995120. PubMed ID: 37983502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
    KrishnaKumar VG; Paul A; Gazit E; Segal D
    Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deciphering the Role of ATP on PHF6 Aggregation.
    Pal S; Roy R; Paul S
    J Phys Chem B; 2022 Jul; 126(26):4761-4775. PubMed ID: 35759245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
    Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.
    Ganguly P; Do TD; Larini L; LaPointe NE; Sercel AJ; Shade MF; Feinstein SC; Bowers MT; Shea JE
    J Phys Chem B; 2015 Apr; 119(13):4582-93. PubMed ID: 25775228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.
    Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T
    Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease.
    Aillaud I; Funke SA
    Cell Mol Neurobiol; 2023 Apr; 43(3):951-961. PubMed ID: 35596819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
    Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
    Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.
    Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.
    Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY
    J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling the Structure and Dynamics of Ac-PHF6-NH
    Stroganova I; Toprakcioglu Z; Willenberg H; Knowles TPJ; Rijs AM
    ACS Chem Neurosci; 2024 Sep; 15(18):3391-3400. PubMed ID: 39215387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.
    Zou Y; Guan L
    Front Mol Biosci; 2021; 8():801577. PubMed ID: 34966788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based inhibitors of tau aggregation.
    Seidler PM; Boyer DR; Rodriguez JA; Sawaya MR; Cascio D; Murray K; Gonen T; Eisenberg DS
    Nat Chem; 2018 Feb; 10(2):170-176. PubMed ID: 29359764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau.
    Li W; Sperry JB; Crowe A; Trojanowski JQ; Smith AB; Lee VM
    J Neurochem; 2009 Aug; 110(4):1339-51. PubMed ID: 19549281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency.
    Murata T; Ito G; Utsunomiya-Tate N
    Biochem Biophys Res Commun; 2023 Apr; 654():18-25. PubMed ID: 36878036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer's Disease.
    Walton-Raaby M; Woods R; Kalyaanamoorthy S
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation.
    Barré P; Eliezer D
    Protein Sci; 2013 Aug; 22(8):1037-48. PubMed ID: 23740819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the force fields on monomeric and fibrillar PHF6 of tau protein.
    Li Y; Peng X
    Biophys Chem; 2021 Oct; 277():106631. PubMed ID: 34116358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.